Genprex GNPX
NASDAQ GNPX
$1.98 -0.07 (-3.41%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genprex (GNPX) Share-based Compensation (2016 - 2026)

Updated

Genprex (GNPX) reported Share-based Compensation of $68,354 for Q2 2026, down 85.0% from $455,499 a year earlier and down 6.9% from the prior quarter.

Analysis

Genprex (GNPX) Share-based Compensation (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Genprex's Share-based Compensation came in at $554,859, down 59.3% year-over-year; for FY2025, it was $1.05 million, down 68.1% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of -24.3% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $3.3 million in FY2024 (-38.9%), $5.41 million in FY2023 (+14.3%), $4.73 million in FY2022 (-11.5%) and $5.35 million in FY2021 (+25.9%).
  • Five-year quarterly Share-based Compensation spans a low of -$62,031 in Q4 2025 and a high of $2.86 million in Q4 2021.
  • Year over year, Share-based Compensation gained in 1 of the last seven quarters, with an average decline of 59.6%.
  • The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 324.9%); the low point was Q2 2026 (a decline of 85.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $73,432 (Q1 2026), -$62,031 (Q4 2025) and $475,104 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 166.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 249.00 Mn
10 Genprex 955,456.02 -41.18 Mn - 70,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70,000.00
Mar 31, 2026 120,000.00
Dec 31, 2025 -363,243.00
Sep 30, 2025 19,553.00
Jun 30, 2025 460,000.00
Mar 31, 2025 184,773.00
Dec 31, 2024 265,034.00
Sep 30, 2024 420,226.00
Jun 30, 2024 2.07 Mn
Mar 31, 2024 542,715.00
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.49 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.33 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 1.22 Mn
Jun 30, 2022 1.15 Mn
Mar 31, 2022 1.06 Mn
Dec 31, 2021 2.86 Mn
Sep 30, 2021 675,378.00
API Access

Genprex Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GNPX&period=max&api_key=YOUR_API_KEY